powered by centersite dot net
Medications
Resources
Basic InformationLatest News
New Cholesterol Drugs Vastly Overpriced, Study ContendsFDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsHealth Tip: Throwing Out Leftover MedicineFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?U.S. Antidepressant Use Jumps 65 Percent in 15 YearsThe Fine Print on Medication Expiration DatesAmericans Taking More Prescription Drugs Than Ever: SurveyInappropriate Med Use High in Cognitively Impaired SeniorsA Reminder That Meds and Grapefruit Don't Always MixAspirin Responsiveness Can Change After Bariatric SurgerySome Medicines Boost Sensitivity to SunPainkiller Prescriptions More Prone to Errors If HandwrittenMedication Mistakes Have Doubled in U.S. Since 2000: StudyMarket Competition Linked to Change in Generic Drug PricesIs Your Child's 'Penicillin Allergy' Real?FDA Seeks to Increase Number of Generic Drugs on MarketWhen Is an Opioid Safe to Take?Lifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyBirth Control Pills Recalled Due to Danger of Unintended PregnancyNew Drugs Show Promise as First to Prevent MigraineMedication Adherence Up With Refill Synchronization ModelModified Vancomycin May Help Fight Bacterial ResistanceScientists Tweak Antibiotic to Boost Power Against 'Superbugs'New Cholesterol Fighting Meds Target Key GeneResearchers Say PDE5 Inhibitors Don't Cause MelanomaNearly a Third of Drugs Hit by Safety Issues After FDA ApprovalU.S. Moves to Avert Shortage of Yellow Fever VaccineOpioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: StudyApril 29 Is National Prescription Drug Take Back DayERs Administering More Medications IntranasallyFDA Warns Against Children Taking Codeine, TramadolPhysicians Finding Ways to Work Around Cost of Rx MedicationsRuling Out Penicillin Allergy by Testing Inpatients Saves MoneyEpiPen Out-of-Pocket Costs More Than Doubled Over DecadeAACR: Regular Aspirin Use Linked to Lower Cancer MortalityFDA Approves Noctiva Nasal Spray for Nocturnal PolyuriaFDA Approves Odactra for House Dust Mite AllergiesHow Much Melatonin Is Really in That Supplement?Antidepressant Efficacy Varies for Depressive Symptom ClustersDo You Need an Antibiotic?'Off-Label' Antidepressants Common, But Where's the Evidence?Docs More Likely to Prescribe Antibiotics If Patients Expect ThemSimilar Adverse Event Risk for Typical, Atypical AntipsychoticsRx Adherence Reminders No More Effective at 'Fresh Start' DatesThink You're Allergic to Penicillin? Check AgainExcessive FDA Regulation Driving High Drug PricesOutcomes-Based Pricing Suggested for New, Costly Drugs
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

Wider Low-Dose Aspirin Use Would Save U.S. $692 Billion: Study

HealthDay News
by -- Robert Preidt
Updated: Nov 30th 2016

new article illustration

WEDNESDAY, Nov. 30, 2016 (HealthDay News) -- Taking low-dose aspirin daily can reduce older Americans' risk of heart disease and cancer, and lead to significant savings in health care spending, a new study contends.

University of Southern California researchers used national data to assess the long-term benefits of daily aspirin usage. They calculated that taking low-dose aspirin every day would prevent 11 cases of heart disease and four cases of cancer for every 1,000 Americans ages 51 to 79.

"Although the health benefits of aspirin are well-established, few people take it," said study lead author Dr. David Agus. He's the founding director and CEO of the university's Lawrence J. Ellison Institute for Transformative Medicine.

"Our study shows multiple health benefits and a reduction in health care spending from this simple, low-cost measure that should be considered a standard part of care for the appropriate patient," Agus said in a university news release.

The study found, for example, that life expectancy would increase by 0.3 years (largely disability-free), which means that out of 1,000 people, eight more would reach age 80 and three more would reach age 100. By 2036, an estimated 900,000 more Americans would be alive, the researchers said.

In addition, daily low-dose aspirin use by older Americans would result in an estimated national net health benefit worth $692 billion, according to the study.

"The irony of our findings is that aspirin may be too cheap," said study co-author Dana Goldman, director of the USC Schaeffer Center for Health Policy and Economics.

"Only 40 percent of Americans are taking aspirin when they should, and providers have little incentive to push that number up, despite the obvious health benefits and health care savings," he noted.

"Until we figure out how to reward providers -- and manufacturers -- for long-term outcomes, no one is going to do anything about this problem," Goldman said.

Low-dose aspirin isn't a magic cure-all, however. The study revealed no significant reduction for stroke incidence. It also indicated that gastrointestinal bleeding would increase 25 percent from the current rate. This means two out of 63 Americans would likely suffer a bleeding incident between ages 51 and 79, the researchers said.

The study results were published Nov. 30 in the journal PLOS ONE.

More information

The U.S. Department of Health and Human Services helps identify who should talk to a doctor about daily low-dose aspirin use.